Latest Mass Tort News and Updates

Another report released this August confirms that Monsanto was involved in influencing and curbing the release of damaging scientific data regarding the safety and efficacy of Roundup…

The third straight win for Xarelto defendants in the Xarelto MDL No. 2592 bellwether trial, boosts the defendant's stand regarding the safety and efficacy of Xarelto. Bayer released a statement saying, ''that its FDA-…

One of the largest verdicts was announced in favor of the plaintiff this August by a California jury: J&J was ordered to pay $417 which included $347 million in punitive damages and $70 million in compensatory damages, making it one of the…

The U.S. Food & Drug Administration (FDA) has finally given a go to Perrigo Company Plc., to market a store-brand equivalent of Nexium 24HR which is an OTC version of Nexium used to treat heartburns. Owing to the fact…

Taxotere, a chemotherapy drug approved by the FDA for treating cancer in 1996, is currently the subject of several lawsuits in multiple states as the announcement hit the news that the first lawsuit filed under MDL…

Invokana lawsuits have shown further movement in the court proceedings with the approval coming forth for the Plaintiff Fact Sheets along with its protocols details by the U.S. District Court, District of New Jersey.…

In spite of a list of side effects linked to Onglyza, there is only some success or positive movement at the plaintiff's end. Last year, 14 of them had their claims dismissed by a federal judge in California who granted the defendant AstraZeneca'…

As the PPI case filings seem to have significantly increased, the Judicial Panel on Multidistrict Litigation (JPML) took a decision to hear the argument of PPI litigations on July 27, 2017, under a new motion to create…

The parent company of Allergan, AbbVie Inc., announced to launch a new awareness campaign to inform women implanted with their recalled Allergan Natrelle…

Another ruling went in favor of the defendant, drug manufacturer Pfizer, for its antidepressant drug Zoloft by a panel of the 3rd U…